Last updated: 11/03/2018 17:16:06

The prevalence of osteoporotic vertebral compression fractures (OVCF) in Korean post menopausal womenTOP

GSK study ID
114777
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: The prevalence of osteoporotic vertebral compression fractures (OVCF) in Korean post menopausal women
Trial description: This is an observational study to investigate the prevalence of osteoporotic fractures in post menopausal patients. Post menopausal patients who visit OS(orthopedic surgery) including GHs(general hospitals) and clinics will be enrolled.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

The prevalence of OVCFs confirmed by history and X-ray

Timeframe: 1 day

Secondary outcomes:

The prevalence of asymptomatic (or missed) fractures

Timeframe: 1 day

Interventions:
Other: Fracture evaluation
Enrollment:
1136
Observational study model:
Other
Primary completion date:
Not applicable
Time perspective:
Cross-Sectional
Clinical publications:
Not applicable
Medical condition
Osteoporosis, Postmenopausal
Product
Not applicable
Collaborators
Not applicable
Study date(s)
October 2010 to February 2011
Type
Observational
Phase
Not applicable

Participation criteria

Sex
Female
Age
50 - 79 years
Accepts healthy volunteers
Yes
  • Subjects who were diagnosed post menopausal state
  • Subjects over 50 years old
  • Subjects who are not confirmed as post menopause state
  • Subjects who do not understand the contents of questionnaire

Trial location(s)

Location
Status
Contact us
Contact us
Location
GSK Investigational Site
Seoul, South Korea, 120-752
Status
Study Complete

Study documents

Scientific result summary
Available language(s): English

If you wish to request for full study report, please contact - [email protected]

Results overview

Refer to study documents

Recruitment status
Finalized
Actual primary completion date
Not applicable
Actual study completion date
2011-22-02

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website